Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Biochemical exploration of β-lactamase inhibitors
Varshaa Arer, Debasish Kar
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 20

Showing 20 citing articles:

Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens
Vikram Kumar, Nusrath Yasmeen, Aishwarya Pandey, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 42
Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria
Song Zhang, Xinyu Liao, Tian Ding, et al.
Antibiotics (2024) Vol. 13, Iss. 3, pp. 260-260
Open Access | Times Cited: 20
The Combination of Antibiotic and Non-Antibiotic Compounds Improves Antibiotic Efficacy against Multidrug-Resistant Bacteria
Gang Xiao, Jiyun Li, Zhiliang Sun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15493-15493
Open Access | Times Cited: 23
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects
Johnny Zakhour, L’Emir Wassim El Ayoubi, Souha S. Kanj
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 4, pp. 189-201
Closed Access | Times Cited: 11
Unveiling the Secrets of Acinetobacter baumannii: Resistance, Current Treatments, and Future Innovations
Andrea Marıno, Egle Augello, Stefano Stracquadanio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6814-6814
Open Access | Times Cited: 8
Failure or future? Exploring alternative antibacterials: a comparative analysis of antibiotics and naturally derived biopolymers
Artemijs Ščeglovs, Ingus Skadiņš, Marco Chittò, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Probing the role of zinc ion in metallo-β-lactamase inhibitor binding by using multiple molecular dynamics simulations
Guodong Zheng, Wuxia Liu, Young-Ku Kang, et al.
Results in Chemistry (2025) Vol. 15, pp. 102171-102171
Open Access
Beyond antibiotics: exploring multifaceted approaches to combat bacterial resistance in the modern era: a comprehensive review
Aref Yarahmadi, Hamide Najafiyan, Mohammad Hasan Yousefi, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Febrile neutropenia management in high-risk neutropenic patients: a Narrative Review on Antibiotic Prophylaxis and empirical treatment
Cemre Boşnak, Murat Akova
Expert Review of Anti-infective Therapy (2025)
Closed Access
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase
Nichole K. Stewart, Márta Tóth, Pojun Quan, et al.
ACS Infectious Diseases (2024) Vol. 10, Iss. 4, pp. 1232-1249
Open Access | Times Cited: 2
Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance
Su‐Jin Kang, Do‐Hee Kim, Bong‐Jin Lee
Biophysical Chemistry (2024) Vol. 309, pp. 107228-107228
Closed Access | Times Cited: 2
High efficacy and enhanced synergistic activity of the novel siderophore-cephalosporin cefiderocol against multidrug-resistant and extensively drug-resistant Klebsiella pneumoniae from inpatients attending a single hospital in the United Arab Emirates
Lana Daoud, Farah Al‐Marzooq, Akela Ghazawi, et al.
Journal of Infection and Public Health (2023) Vol. 16, pp. 33-44
Open Access | Times Cited: 6
Potentiation of Antibiotic Activity of Aztreonam against Metallo-β-Lactamase-Producing Multidrug-Resistant Pseudomonas aeruginosa by 3-O-Substituted Difluoroquercetin Derivatives
Seongyeon Lee, Taegum Lee, Mi Kyoung Kim, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 185-185
Open Access | Times Cited: 1
Revisiting the Checkerboard to Inform Development of β-Lactam/β-Lactamase Inhibitor Combinations
Darren Bentley
Antibiotics (2024) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 1
Current Strategy for Targeting Metallo-β-Lactamase with Metal-Ion-Binding Inhibitors
Jessica L. Ortega-Balleza, Lenci K. Vázquez‐Jiménez, Eyra Ortiz‐Pérez, et al.
Molecules (2024) Vol. 29, Iss. 16, pp. 3944-3944
Open Access | Times Cited: 1
Strategic re-engineering of antibiotics
Joshua A. Homer, Robert Johnson, Rebecca A. Koelln, et al.
Nature Reviews Bioengineering (2024)
Closed Access | Times Cited: 1
Exploiting the Carboxylate-Binding Pocket of β-Lactamase Enzymes Using a Focused DNA-Encoded Chemical Library
Suhyeorn Park, Jiayi Fan, Srinivas Chamakuri, et al.
Journal of Medicinal Chemistry (2023) Vol. 67, Iss. 1, pp. 620-642
Closed Access | Times Cited: 4
Deeper insights into the action of class C β-lactamases against cephalosporins through molecular docking and MD simulation studies
Varshaa Arer, Ananya Anurag Anand, Sintu Kumar Samanta, et al.
Biologia (2024) Vol. 79, Iss. 12, pp. 3695-3709
Closed Access
Lactamase and antibiotic resistance: A catalyst for drug discovery breakthroughs
Mukesh Kumar, Shivani Mishra, Shantanu Chowdhury, et al.
Elsevier eBooks (2024), pp. 215-248
Closed Access
In-Vitro Activity of Dimercaptosuccinic Acid in Combination with Carbapenems Against Carbapenem-Resistant Pseudomonas aeruginosa
Maxime Bouvier, Samanta Freire, Jacqueline Findlay, et al.
Microbial Drug Resistance (2024)
Closed Access
Pénicillines et inhibiteurs de bêtalactamases
Anaëlle Muggeo, Diane Lebrun, M. Bonnet, et al.
EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses (2024) Vol. 41, Iss. 4, pp. 1-16
Closed Access
Page 1

Scroll to top